otezla apremilast 20 mg
1 INDICATIONS AND USAGE OTEZLA, an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of: Adult patients with active psoriatic arthritis ( 1.1 ) Patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy ( 1.2 ) Adult patients with oral ulcers associated with Behçet's Disease ( 1.3 ) 1.1 Psoriatic Arthritis OTEZLA is indicated for the treatment of adult patients with active psoriatic arthritis. 1.2 Psoriasis OTEZLA is indicated for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. 1.3 Oral Ulcers Associated with Behçet's Disease OTEZLA is indicated for the treatment of adult patients with oral ulcers associated with Behçet's Disease.
Celgene Corporation
DIAMOND BROWN APR 20
APR 20 DIAMOND BROWN
Related Pills
otezla apremilast 30 mg
celgene corporation
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING OTEZLA is available as diamond-shaped, film-coated tablets in the following dosage strengths: 10-mg pink tablet engraved with "APR" on one side and "10" on the other side; 20-mg brown tablet engraved with "APR" on one side and "20" on the other side; 30-mg beige tablet engraved with "APR" on one side and "30" on the other side. Tablets are supplied in the following strengths and package configurations: Package configuration Tablet strength NDC number Bottles of 60 30 mg 59572-631-06 Two-week starter pack 13-tablet blister titration pack containing: (4) 10-mg, (4) 20-mg, and (5) 30-mg tablets with an additional (14) 30-mg tablets 59572-630-27 28-count carton Two 30-mg blister cards containing (14) 30-mg tablets 59572-631-28 28-day starter pack 13-tablet blister titration pack containing: (4) 10-mg, (4) 20-mg, and (5) 30-mg tablets with an additional (42) 30-mg tablets 59572-632-55 Storage and Handling Store tablets below 30°C (86°F).
More pills like DIAMOND APR 20